These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Phototoxicity and antipsoriatic effect of a topical methoxypsoralen solution in relation to the application time. Meffert H, Andersen KE, Sönnichsen N. Photodermatol; 1984 Aug 07; 1(4):191-4. PubMed ID: 6531293 [Abstract] [Full Text] [Related]
6. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review. Archier E, Devaux S, Castela E, Gallini A, Aubin F, Le Maître M, Aractingi S, Bachelez H, Cribier B, Joly P, Jullien D, Misery L, Paul C, Ortonne JP, Richard MA. J Eur Acad Dermatol Venereol; 2012 May 07; 26 Suppl 3():22-31. PubMed ID: 22512677 [Abstract] [Full Text] [Related]
7. 5-Methoxypsoralen. A review of its effects in psoriasis and vitiligo. McNeely W, Goa KL. Drugs; 1998 Oct 07; 56(4):667-90. PubMed ID: 9806110 [Abstract] [Full Text] [Related]
8. [Semen analysis under photochemotherapy (PUVA-therapy) (author's transl)]. Schill WB, Hofmann C, Plewig G. Arch Dermatol Res; 1979 Mar 31; 264(2):153-60. PubMed ID: 464634 [Abstract] [Full Text] [Related]
9. Skin photosensitizing and Langerhans' cell depleting activity of topical (bath) PUVA therapy: comparison of trimethylpsoralen and 8-methoxypsoralen. Koulu L, Jansén CT. Acta Derm Venereol; 1983 Mar 31; 63(2):137-41. PubMed ID: 6189328 [Abstract] [Full Text] [Related]
10. Safety and therapeutic effectiveness of selected psoralens in psoriasis. Wolff K, Hönigsmann H. Natl Cancer Inst Monogr; 1984 Dec 31; 66():159-64. PubMed ID: 6531023 [Abstract] [Full Text] [Related]
11. [Systemic photoallergy induced by methoxalen]. Jeanmougin M, Manciet JR, Castelneau JP, Smadja J, Dubertret L. Ann Dermatol Venereol; 1992 Dec 31; 119(4):277-80. PubMed ID: 1530240 [No Abstract] [Full Text] [Related]
13. Development of acute myeloid leukaemia in a patient with psoriasis treated with oral 8-methoxypsoralen and longwave ultraviolet light. Hansen NE. Scand J Haematol; 1979 Jan 31; 22(1):57-60. PubMed ID: 284581 [Abstract] [Full Text] [Related]
14. Serum concentration and phototoxic effect of methoxsalen in patients with psoriasis. Swanbeck G, Ehrsson H, Ehrnebo M, Wallin I, Jonsson L. Clin Pharmacol Ther; 1979 Apr 31; 25(4):478-80. PubMed ID: 428192 [Abstract] [Full Text] [Related]
15. Hepatitis from 5-methoxypsoralen occurring in a patient with previous flucloxacillin hepatitis. Stephens RB, Cooper A. Australas J Dermatol; 1999 Nov 31; 40(4):217-9. PubMed ID: 10570561 [Abstract] [Full Text] [Related]
16. Systemic allergic contact dermatitis to 8-methoxypsoralen (8-MOP). Ravenscroft J, Goulden V, Wilkinson M. J Am Acad Dermatol; 2001 Dec 31; 45(6 Suppl):S218-9. PubMed ID: 11712064 [Abstract] [Full Text] [Related]
17. [Problems posed by the therapeutic use of photosensitizers in dermatology]. Beani JC, Amblard P, Reymond JL. Biochimie; 1986 Jun 31; 68(6):905-12. PubMed ID: 2944547 [Abstract] [Full Text] [Related]
18. Liver biopsy in PUVA-treated patients. Zachariae H, Kragballe K, Søgaard H. Acta Derm Venereol; 1979 Jun 31; 59(3):268-70. PubMed ID: 87091 [Abstract] [Full Text] [Related]
19. Cutaneous drug eruption caused by 8-methoxypsoralen. Cox NH, Rogers S. Photodermatol; 1989 Apr 31; 6(2):96-7. PubMed ID: 2526323 [No Abstract] [Full Text] [Related]
20. Allergic contact and photocontact dermatitis due to psoralens in patients with psoriasis treated with topical PUVA. Takashima A, Yamamoto K, Kimura S, Takakuwa Y, Mizuno N. Br J Dermatol; 1991 Jan 31; 124(1):37-42. PubMed ID: 1993143 [Abstract] [Full Text] [Related] Page: [Next] [New Search]